A synthetic neuraminidase substrate [2-(3'-methoxyphenyl)-N-acetyl-a-neuraminic acid] was used to detect myxo-and paramyxovirus replication in tissue culture. This method allowed estimation of viral growth even in the absence of cytopathogenic effects.
One of the proteins present in the envelopes of most myxo-and paramyxovirus particles is the enzyme neuraminidase (EC 3.2.1.18). There is good evidence that this enzyme, which is coded by the viral genome, plays a significant role in the virus growth cycle (1, 10, 12) . In tissues infected in vitro or in vivo with myxoviruses, a marked increase in neuraminidase activity has been observed (4-6, 8, 9) . Recently a chromogenic substrate, 2-(3'-methoxyphenyl) -N-acetyl-a -neuraminic acid (MPN), has been described, which is cleaved by viral and other neuraminidases exclusively (11) . The 3-methoxyphenol released enzymatically produces a red dye when coupled with the diazonium salt of 4-amino-2 , 5-dimethoxy-4'-nitroazobenzene (DS). As reported in this communication, the chromogenic substrate can be used to visualize and to assess the propagation of viruses which are associated with strong neuraminidase activity in tissue monolayer cultures. Fig. 2, 48 hr after infection, plaques due to cytopathogenicity of the virus and neuraminidase foci were both observable, the counts being closely similar. The numbers of foci and plaques were proportional to the concentration of the virus inoculum (Fig. 1) .
The chromogenic neuraminidase substrate could also be employed for the assay of influenza A2 virus, strain Vienna genic effects. However, neuraminidase foci could readily be detected by incubation with MPN and coupling with DS at 30 hr postinfection or later, as demonstrated for NDV-infected monolayer cultures. Numbers of foci per dish varied from 50 to 100 at 48 hr postinfection. To prove the viral origin of foci, antiserum !qgainst influenza A2, strain Vienna 83, was added at a dilution of 1 :10 to controls during the adsorption period. (Antiserum prepared from infected mice with a hemagglutinin-inhibition titer of 210 was kindly supplied by C. Kunz.) No foci could be detected in antiserum treated controls.
Measles virus, strain Edmonston, was titrated in monolayers of human amnion cells (U-line, supplied by Cari Cantell, University of Helsinki) by the method of de Jong (3). Plaques could be detected, 7 to 12 days after infection, by staining with gentian violet. However, no neuraminidase foci could be found by the new technique described above. This can be explained by the fact that measles virus contains very little (2), if any, neuraminidase activity. Stock measles virus, concentrated by ultracentrifugation (212 HA units/ ml), did not exhibit neuraminidase activity when tested with the phenylketoside of N-acetylneuraminic acid as substrate by the method of Meindl and Tuppy (7) .
These results demonstrate that the new method can be successfuily used for the assay of myxoand paramyxoviruses which contain neuraminidase, even if no cytopathogenic effect is seen during replication. A prospective application of the method is the in vitro screening of antimyxoviral substances.
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